Top

Journal of Gastrointestinal Surgery

Published in:

Open Access 01-08-2012 | Original Article

The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European Survey

Enzyme Replacement After Surgery

Authors: Edmée C. M. Sikkens, Djuna L. Cahen, Casper van Eijck, Ernst J. Kuipers, Marco J. Bruno

Published in: Journal of Gastrointestinal Surgery | Issue 8/2012

Abstract

Introduction

After pancreatic surgery, up to 80 % of patients will develop exocrine insufficiency. For enzyme supplementation to be effective, prescribing an adequate dose of pancreatic enzymes is mandatory but challenging because the required dose varies. Data on the practice of enzyme replacement therapy after surgery are lacking, and therefore, we conducted this analysis.

Methods

An anonymous survey was distributed to members of the Dutch and German patient associations for pancreatic disorders. The target population consisted of patients with chronic pancreatitis or pancreatic cancer who had undergone pancreatic surgery and were using enzymes to treat exocrine insufficiency. Results were compared to a similar group of non-operated patients.

Results

Ninety-one cases were analyzed (84 % underwent a resection procedure). The median daily enzyme dose was 6, and 25 % took three or less capsules. Despite treatment, 68 % of patients reported steatorrhea-related symptoms, 48 % adhered to a non-indicated dietary fat restriction, and only 33 % had visited a dietician. The outcome was equally poor for the 91 non-operated patients.

Conclusion

Most patients suffering from exocrine insufficiency after pancreatic surgery are undertreated. To improve efficacy, physicians should be more focused on treating exocrine insufficiency and educate patients to adjust the dose according to symptoms and their diet.

Available only for authorised users

Lankisch PG, Lembcke B, Wemken G, Creutzfeldt W: Functional reserve capacity of the exocrine pancreas. Digestion 1986;35:175–181.PubMedCrossRef

Layer P, Go VL, DiMagno EP: Fate of pancreatic enzymes during small intestinal aboral transit in humans. Am J Physiol 1986;251:G475–480.PubMed

Tran TC, van’t Hof G, Kazemier G, Hop WC, Pek C, van Toorenenbergen AW, van Dekken H, van Eijck CH: Pancreatic fibrosis correlates with exocrine pancreatic insufficiency after pancreatoduodenectomy. Dig Surg 2008;25:311–318.PubMedCrossRef

Bruno MJ: Maldigestion and exocrine pancreatic insufficiency after pancreatic resection for malignant disease: Pathofysiology and treatment. Pancreatology 2001;1:55–61.CrossRef

Cahen DL, Gouma DJ, Nio Y, Rauws EA, Boermeester MA, Busch OR, Stoker J, Lameris JS, Dijkgraaf MG, Huibregtse K, Bruno MJ: Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007;356:676–684.PubMedCrossRef

Riediger H, Adam U, Fischer E, Keck T, Pfeffer F, Hopt UT, Makowiec F: Long-term outcome after resection for chronic pancreatitis in 224 patients. J Gastrointest Surg 2007;11:949–959; discussion 959–960.PubMedCrossRef

Kato H, Nakao A, Kishimoto W, Nonami T, Harada A, Hayakawa T, Takagi H: 13c-labeled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy. Am J Gastroenterol 1993;88:64–69.PubMed

Pasquali C, Fogar P, Sperti C, Basso D, De Paoli M, Plebani M, Pedrazzoli S: Efficacy of a pancreatic enzyme formulation in the treatment of steatorrhea in patients with chronic pancreatitis. Current Therapeutic Research - Clinical and Experimental 1996;57:358–365.CrossRef

Rivers JP, Hassam AG: Defective essential-fatty-acid metabolism in cystic fibrosis. Lancet 1975;2:642–643.PubMedCrossRef

10.

Roberts IM: Enzyme therapy for malabsorption in exocrine pancreatic insufficiency. Pancreas 1989;4:496–503.PubMedCrossRef

11.

Rosenlund ML, Kim HK, Kritchevsky D: Essential fatty acids in cystic fibrosis. Nature 1974;251:719.PubMedCrossRef

12.

Dutta SK, Bustin MP, Russell RM, Costa BS: Deficiency of fat-soluble vitamins in treated patients with pancreatic insufficiency. Ann Intern Med 1982;97:549–552.PubMed

13.

Kalivianakis M, Minich DM, Bijleveld CM, van Aalderen WM, Stellaard F, Laseur M, Vonk RJ, Verkade HJ: Fat malabsorption in cystic fibrosis patients receiving enzyme replacement therapy is due to impaired intestinal uptake of long-chain fatty acids. Am J Clin Nutr 1999;69:127–134.PubMed

14.

Lankisch PG, Lembcke B, Goke B, Creutzfeldt W: Therapy of pancreatogenic steatorrhoea: Does acid protection of pancreatic enzymes offer any advantage? Z Gastroenterol 1986;24:753–757.PubMed

15.

Sikkens EC, Cahen DL, Kuipers EJ, Bruno MJ: Pancreatic enzyme replacement therapy in chronic pancreatitis. Best Pract Res Clin Gastroenterol 2010;24:337–347.PubMedCrossRef

16.

Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ: Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Gut 1998;42:92–96.PubMedCrossRef

17.

Gullo L, Stella A, Labriola E, Costa PL, Descovich G, Labo G: Cardiovascular lesions in chronic pancreatitis: A prospective study. Dig Dis Sci 1982;27:716–722.PubMedCrossRef

18.

Gullo L, Tassoni U, Mazzoni G, Stefanini F: Increased prevalence of aortic calcification in chronic pancreatitis. Am J Gastroenterol 1996;91:759–761.PubMed

19.

Mundlos S, Kuhnelt P, Adler G: Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 1990;31:1324–1328.PubMedCrossRef

20.

DiMagno EP, Malagelada JR, Go VL, Moertel CG: Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules. N Engl J Med 1977;296:1318–1322.PubMedCrossRef

21.

Keller J, Runzi M, Goebell H, Layer P: Duodenal and ileal nutrient deliveries regulate human intestinal motor and pancreatic responses to a meal. Am J Physiol 1997;272:G632–637.PubMed

22.

Layer P, Peschel S, Schlesinger T, Goebell H: Human pancreatic secretion and intestinal motility: Effects of ileal nutrient perfusion. Am J Physiol 1990;258:G196–201.PubMed

23.

Layer P, Schlesinger T, Groger G, Goebell H: Modulation of human periodic interdigestive gastrointestinal motor and pancreatic function by the ileum. Pancreas 1993;8:426–432.PubMedCrossRef

24.

Layer P, von der Ohe MR, Holst JJ, Jansen JB, Grandt D, Holtmann G, Goebell H: Altered postprandial motility in chronic pancreatitis: Role of malabsorption. Gastroenterology 1997;112:1624–1634.PubMedCrossRef

25.

Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar GB, Hall JC, Moss G, Morris AP, O’Neill B, et al.: Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984;86:274–280.PubMed

26.

Rosa ESL, Troncon LE, Gallo L, Jr., Foss MC, Passos AD, Perdona GC, Achcar JA, Oliveira RB (2010) Determinants of accelerated small intestinal transit in alcohol-related chronic pancreatitis. Dig Dis Sci 55(4):1017-25CrossRef

27.

Zentler-Munro PL, Fitzpatrick WJ, Batten JC, Northfield TC: Effect of intrajejunal acidity on aqueous phase bile acid and lipid concentrations in pancreatic steatorrhoea due to cystic fibrosis. Gut 1984;25:500–507.PubMedCrossRef

28.

Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas. Gut 2005;54 Suppl 5:v1–16.

29.

Dominguez-Munoz JE: Pancreatic enzyme replacement therapy: Exocrine pancreatic insufficiency after gastrointestinal surgery. HPB (Oxford) 2009;11 Suppl 3:3–6.CrossRef

30.

Ito K: Duodenum preservation in pancreatic head resection to maintain pancreatic exocrine function (determined by pancreatic function diagnostant test and cholecystokinin secretion). J Hepatobiliary Pancreat Surg 2005;12:123–128.PubMedCrossRef

31.

Braga M, Cristallo M, De Franchis R, Mangiagalli A, Zerbi A, Agape D, Primignani M, Di Carlo V: Pancreatic enzyme replacement therapy in post-pancreatectomy patients. Int J Pancreatol 1989;5 Suppl:37–44.PubMed

32.

Barreiro-de Acosta M, Lorenzo A, Dominguez-Munoz JE: Adalimumab in ulcerative colitis: Two cases of mucosal healing and clinical response at two years. World J Gastroenterol 2009;15:3814–3816.PubMedCrossRef

33.

Bruno MJ, Borm JJ, Hoek FJ, Delzenne B, Hofmann AF, de Goeij JJ, van Royen EA, van Gulik TM, de Wit LT, Gouma DJ, van Leeuwen DJ, Tytgat GN: Comparative effects of enteric-coated pancreatin microsphere therapy after conventional and pylorus-preserving pancreatoduodenectomy. Br J Surg 1997;84:952–956.PubMedCrossRef

34.

Ramo OJ, Puolakkainen PA, Seppala K, Schroder TM: Self-administration of enzyme substitution in the treatment of exocrine pancreatic insufficiency. Scand J Gastroenterol 1989;24:688–692.PubMedCrossRef

35.

Dominguez-Munoz JE, Iglesias-Garcia J, Iglesias-Rey M, Figueiras A, Vilarino-Insua M: Effect of the administration schedule on the therapeutic efficacy of oral pancreatic enzyme supplements in patients with exocrine pancreatic insufficiency: A randomized, three-way crossover study. Aliment Pharmacol Ther 2005;21:993–1000.PubMedCrossRef

36.

Keller J, Layer P: Pancreatic enzyme supplementation therapy. Curr Treat Options Gastroenterol 2003;6:369–374.PubMedCrossRef

37.

Keller J, Layer P: Human pancreatic exocrine response to nutrients in health and disease. Gut 2005;54 Suppl 6:vi1–28.PubMed

38.

Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP: The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994;107:1481–1487.PubMed

Title: The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European Survey
Enzyme Replacement After Surgery
Authors: Edmée C. M. Sikkens
Djuna L. Cahen
Casper van Eijck
Ernst J. Kuipers
Marco J. Bruno
Publication date: 01-08-2012
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 8/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-012-1927-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The Daily Practice of Pancreatic Enzyme Replacement Therapy After Pancreatic Surgery: a Northern European Survey

Enzyme Replacement After Surgery

Abstract

Introduction

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2012

Improved Quality of Life Following Total Pancreatectomy and Auto-islet Transplantation for Chronic Pancreatitis

Topically Applied 2-Octyl Cyanoacrylate (Dermabond) for Prevention of Postoperative Pancreatic Fistula After Pancreaticoduodenectomy

Impact of Simultaneous Diaphragm Resection During Hepatectomy for Treatment of Metastatic Colorectal Cancer

Unexpected Gallbladder Cancer after Laparoscopic Cholecystectomy for Acute Cholecystitis: A Worrisome Picture

Impact of Lymphatic Vessel Invasion on Survival in Gastric Cancer

Single-Incision Laparoscopic Cholecystectomy vs. Conventional Laparoscopic Cholecystectomy: a Meta-analysis of Randomized Controlled Trials